Article
In a recent study involving 537 patients, anti-inflammatory dose doxycycline achieved a statistically significant reduction in inflammatory lesion counts over placebo.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.